The AstraZeneca-backed cancer drug developer had hoped to raise up to $212m in a US flotation but is instead pulling back due to unfavourable market conditions.

Emtek is set to sell up to $55m of its shares in online real estate platform PropertyGuru in an Australian initial public offering that could bring in up to $257m in proceeds.

AstraZeneca spinoff Viela Bio has gone public in an offering that involved existing backers buying some $70m worth of stock, and its share price has since risen 21.7%.

The Alphabet unit has already divested part of its stake in publicly-listed Uber to SoftBank at a $48bn valuation but is considering selling the rest from next month.

Founded from University of Surrey's Space Centre, iKinema was bought by Apple in a move seemingly aligned with the corporate's foray into virtual and augmented reality.

Karolinska Institute's Aprea Therapeutics has priced its shares at $15 to raise $85m, with stock rising a third to $20.50 on the first day of trading.

WarnerMedia, WPP, Discovery Communications and Scripps Networks Interactive will exit the digital media company in a cash and share acquisition.

SIG-backed online content advertiser Outbrain has been acquired for $250m in cash and a 30% stake in competitor Taboola.

Praktikertjänst-backed Aprea Therapeutics has priced its shares at $15 to raise $85m, with stock rising a third to $20.50 on the first day of trading.

Frequency, a regenerative medicine developer based on MIT and Harvard research, priced shares at the bottom of its range to raise $84m in its IPO.